News
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.
The funds will be used to increase the company's development into new automated orthopedic indications and deploy its manufacturing model.
The company will use the funds to broaden its product line and boost recruitment.
The AI voice tool maker will power WellSky’s AI ambient listening to generate clinical notes within its EHR for behavioral health, long-term acute care and rehab facilities.
By teaming up with Fivetran, Hippocratic AI will be able to reproduce its customer data in an analytical environment.
Eli Lilly and Company says the partnership will result in the development of the most powerful supercomputer owned by a pharmaceutical company.
Its chest X-ray analysis AI tool is the first to receive Europe's clearance for use in children aged 0-3.
The certifications show that the company meets globally recognized standards for medical imaging.